The organic chemistry of drug design and drug action / (Record no. 15920)

MARC details
000 -LEADER
fixed length control field 01560nam a2200253Ia 4500
003 - CONTROL NUMBER IDENTIFIER
control field NULRC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250520102818.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 250520s9999 xx 000 0 und d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780123820303
040 ## - CATALOGING SOURCE
Transcribing agency NULRC
050 ## - LIBRARY OF CONGRESS CALL NUMBER
Classification number RS 403 .S55 2014
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Silverman, Richard B.
Relator term author
245 #4 - TITLE STATEMENT
Title The organic chemistry of drug design and drug action /
Statement of responsibility, etc. Richard B. Silverman and Mark W. Holladay
250 ## - EDITION STATEMENT
Edition statement Third edition.
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. San Diego, California :
Name of publisher, distributor, etc. Academic Press,
Date of publication, distribution, etc. c2014
300 ## - PHYSICAL DESCRIPTION
Extent xvii, 517 pages :
Other physical details color illustrations ;
Dimensions 29 cm.
365 ## - TRADE PRICE
Price amount USD58.98
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc. note Includes index.
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note Introduction -- Lead discovery and lead modification -- Receptors -- Enzymes -- Enzyme inhibition and inactivation -- Dna-interactive agents -- Drug resistance and drug synergism -- Drug metabolism -- Prodrugs and drug delivery systems.
520 ## - SUMMARY, ETC.
Summary, etc. The Organic chemistry of drug design and drug action, Third edition, represents a unique approach to medicinal chemistry based on physical organic chemical principles and reaction mechanisms that rationalize drug action, which allows the reader to extrapolate those core principles and mechanisms to many related classes of drug molecules. This new edition reflects significant changes in the process of drug design over the last decade. It preserves the successful approach of the previous editions while including significant changes in format and coverage.
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element PHARMACEUTICAL CHEMISTRY
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Holladay, Mark W.
Relator term co-author
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Library of Congress Classification
Koha item type Books
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Collection Home library Current library Shelving location Date acquired Source of acquisition Cost, normal purchase price Total checkouts Full call number Barcode Date last seen Copy number Price effective from Koha item type
    Library of Congress Classification     Pharmacy LRC - Main National University - Manila General Circulation 06/14/2017 Purchased - Amazon 58.98   GC RS 403 .S55 2014 NULIB000013679 05/20/2025 c.1 05/20/2025 Books